期刊文献+

三维适形放疗序贯替吉奥化疗治疗高龄局部晚期直肠癌患者的疗效观察 被引量:5

Clinical Observation of Three-dimensional Conformal Radiotherapy Combined with S-1 Sequen- tial Chemotherapy for the Treatment of Elderly Patients with Locally Advanced Rectal Cancer
下载PDF
导出
摘要 【目的】评价三维适形放疗序贯替吉奥化疗高龄局部晚期直肠癌患者的临床疗效及毒副反应。【方法】对30例非手术的高龄局部晚期直肠癌患者予以三维适形放射治疗并序贯替吉奥胶囊(S-1)口服化疗4周期。三维适形放射治疗方案:90%~95%处方剂量线,每次3~4Gy,每周5次,总剂量36~40Gy,生物等效剂量46.8~50.4Gy。替吉奥化疗方案:40mg/m2,2次/日,连续给药4周,休息2周为1个周期。化疗4周期后行直肠镜等检查评价疗效,以后定期随访复查。【结果】完全缓解10例,部分缓解17例,稳定2例,进展1例,近期总有效率90.0%。1,2,3年生存率分别为1()()%、86.7%、63.3%。主毒副反应为下消化道反应,其中Ⅲ级反应2例。其余均为I~Ⅱ级。【结论】三维适形放疗序贯替吉奥化疗高龄局部晚期直肠癌患者的疗效好,毒副反应轻。 [Objective]To evaluate the clinical efficacy and side reactions of three-dimensional conformal radiotherapy combined with S-1 for elderly patients with locally advanced rectal cancer. [Methods]Thirty eld- erly patients with locally advanced rectal cancer receiving nonsurgical therapy were treated by three-dimensional conformal radiotherapy combined with S-1 sequential chemotherapy orally for 4 weeks. Three-dimensional con- formal radiotherapy scheme was 90 % -95 % prescribe dose 3-4Gy once for 5 times per week, the total dose of 36-40Gy and biological effective dose of 46.8-50.4Gy. S-1 scheme was -1 40mg/m2 twice a day for 4 successive weeks and rest for 2 week as a cycle. Colonoscopy and other examinations 4 weeks after chemother- apy were used for evaluating the efficacy. All patients were followed up and reexamined regularly. [Results] Among all patients, 10 patients were complete remission, and 17 patients were partial remission, and 2 pa- tients were stable, and 1 patient was progressive, and the short-term effective rate was 90.00%. The 1, 2 and 3-year survival rate was 100%, 86.7% and 63.3%0, respectively. The main side reaction was lower digestive tract response. Grade III toxicities occurred in 2 patients, and grade I^II toxicities occurred in other patients. [Conclusion]Three-dimensional conformal radiotherapy combined with S-1 sequential chemotherapy for the treatment of elderly patients with locally advanced rectal cancer has good effect with mild side reactions.
机构地区 解放军第
出处 《医学临床研究》 CAS 2013年第7期1294-1296,共3页 Journal of Clinical Research
关键词 直肠肿瘤 放射疗法 直肠肿瘤 药物疗法 Rectal Neoplasms/RA Rectal Neoplasms/DT
  • 相关文献

参考文献7

二级参考文献45

  • 1Janja Ocvirk,Thomas Brodowicz,Fritz Wrba,Tudor E Ciuleanu,Galina Kurteva,Semir Beslija,Ivan Koza,Zsuzsanna Pápai,Diethelm Messinger,Ugur Yilmaz,Zsolt Faluhelyi,Suayib Yalcin,Demetris Papamichael,Miklós Wenczl,Zrinka Mrsic-Krmpotic,Einat Shacham-Shmueli,Damir Vrbanec,Regina Esser,Werner Scheithauer,Christoph C Zie-linski.Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial[J].World Journal of Gastroenterology,2010,16(25):3133-3143. 被引量:17
  • 2NELSON H,PETRELLI N,CARLIN A,et al.Guidelines 2000 for colon and rectal cancer surgery[J].J Natl Cancer Inst,2001,93(8):583-596.
  • 3SAWADA N,ISHIKAWA T,SEKIGUCHI F,et al.X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts[J].Clin Cancer Res,1999,5(10):2948-2953.
  • 4KJELLSTR(O)M J,KJELL(E)N E,JOHNSSON A.In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line[J].Acta Oncol,2005,44(7):687-693.
  • 5SAUER R,BECKER H,HOHENBERGER W,et al.Preoperative versus postoperative chemoradiotherapy for rectal cancer[J].N Engl J Med,2004,351(17):1731-1740.
  • 6JANJAN N A,ABBRUZZESE J,PAZDUR R,et al.Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer[J].Radiother Oncol,1999,51(2):153-160.
  • 7GLYNNE-JONES R,SEBAG-MONTEFOLRE D,MAUGHAN T S,et al.A phase Ⅰ dose escalation study of continuous oral capeci-tabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer[J].Ann Oncol,2006,17(1):50-56.
  • 8MACHIELS J P,DUCK L,HONHON B,et al.Phase Ⅱ study of preoperative oxaliplatin,capecitabine and external beam radiotherapy in patients with rectal cancer:The RadiOxCape study[J].Ann Oncol,2005,16(12):1898-1905.
  • 9RUTTERN H,SEBAG-MONTEFLORI D,GLYNNE-JONES R,et al.Capecitabine,oxaliplatin,radiotherapy,and excision (CORE) in patients with MRI-defined locall advanced rectal adenocarcinoma:results of an international multicenter phase Ⅱ study[J].J Clin Oncol,2006 (suppl; abstr 3528)24:153s.
  • 10RODEL C,LIERSCH T,HERMANN R M,et al.Multicenter phase Ⅱ trial of chemoradiation with oxaliplatin for rectal cancer[J].J Clin Oncol,2007,25(1):110-117.

共引文献70

同被引文献43

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部